Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Sep;37(9):e110-e112.
doi: 10.1097/IAE.0000000000001814.

Reply

Ilkay K Muftuoglu  1 , Mostafa Alam, Qi Sheng You, Raouf Gaber, Hema L Ramkumar, Nadia Mendoza, Amit Meshi, William R Freeman
Affiliations
Comment

Reply

Ilkay K Muftuoglu et al. Retina. 2017 Sep.

Abstract

The authors are commenting the letter to editor regarding article entitled “Long-term remission of neovascular age-related macular degeneration with as-needed anti-vascular endothelial growth factor therapy” published in Retina Journal 2017; Doi:10.1097/IAE.0000000000001572. February 17, 2017.

PubMed Disclaimer

Comment on

References

    1. Călugăru D, Călugăru M. Letter to the editor: Long-term remission of neovascular age-related macular degeneration with as-needed anti-vascular endothelial growth factor therapy - PMC - PubMed
    1. Muftuoglu IK, Alam M, You QS, et al. Long-term remission of neovascular age-related macular degeneration with as-needed anti-vascular endothelial growth factor therapy. Retina. 2017 Feb 17; doi: 10.1097/IAE.0000000000001572. [Epub ahead of print] - DOI - PMC - PubMed
    1. Daniel E, Shaffer J, Ying GS, et al. Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Ophthalmology. 2016;123:609–616. - PMC - PubMed
    1. Maguire MG, Martin DF, Ying GS, et al. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-related macular degeneration Treatments Trial. Ophthalmology. 2016;123:1751–1761. - PMC - PubMed
    1. Muftuoglu IK, Tsai FF, Gaber R, Alam M, Meshi A, Freeman WR. High-frequency aflibercept injections in persistent neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017;255:709–717. - PubMed